Researchers have yet to develop well-tolerated and accepted therapies for increasing high-density lipoprotein cholesterol (HDL-C),
the “good” cholesterol, but that does not mean they are not trying.
Much effort over the past several decades has focused on reducing overall cholesterol levels—an effort that has been fairly successful.
A 2005-2006 survey found the average cholesterol level for US adults was under 200 mg/dL for the first time in almost 50 years, according to the US Centers for Disease Control and Prevention. Statin therapy,
the mainstay in the cholesterol fight, is credited with reducing coronary artery disease by about 30%.
Graphic Jump Location
Researchers are exploring ways of increasing high-density lipoprotein cholesterol levels to reduce cardiovascular disease risk.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 1
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
Users' Guides to the Medical Literature
For example, ecologic studies such as the Seven Countries Study16 suggested a strong...
All results at
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.